What Catsci say about themselves
“CatSci is a UK-based award-winning drug development partner for global biotech and pharma teams developing novel small molecule and complex therapies.”
“CatSci is a UK-based award-winning drug development partner for global biotech and pharma teams developing novel small molecule and complex therapies.”
Officer details are public data from the Companies House register.
People and entities with significant control, from the Companies House PSC register
Figures from 2021 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
| 2021 | 2020 | 2019 | |
|---|---|---|---|
| Fixed Assets | £2,147,705 | £1,431,517 | £998,096 |
| Current Assets | £3,393,421 | £1,608,047 | £1,364,137 |
| Debtors | £1,682,952 | £1,028,447 | £805,730 |
| Cash | £1,697,906 | £533,134 | £540,440 |
| Creditors (< 1 year) | £1,275,935 | £558,673 | £435,501 |
| Creditors (> 1 year) | £1,656,930 | £681,755 | £621,291 |
| Net Current Assets | £2,117,486 | £1,049,374 | £928,636 |
| Net Assets | £2,113,410 | £1,532,136 | £1,121,441 |
| Shareholder Funds | £2,113,410 | £1,532,136 | £1,121,441 |
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 4 November 2026 | Confirmation statement with no updates | 4 November 2026 | ||
| 15 September 2026 | Full accounts | 31 December 2025 | ||
| 15 April 2026 | Satisfaction of a charge in full | |||
| 26 February 2026 | Other filing | — | ||
| 17 February 2026 | Registration of a charge |
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →